Literature DB >> 25705460

The crystal structures of four N-(4-halophen-yl)-4-oxo-4H-chromene-3-carboxamides.

Ligia R Gomes1, John Nicolson Low2, Fernando Cagide3, Fernanda Borges3.   

Abstract

Four N-(4-halophen-yl)-4-oxo-4H-chromene-3-carboxamides (halo = F, Cl, Br and I), n class="Chemical">N-(4-fluoro-phen-yl)-4-oxo-4H-chromene-3-carboxamide, C16H10FNO3, N-(4-chloro-phen-yl)-4-oxo-4H-chromene-3-carboxamide, C16H10ClNO3, N-(4-bromo-phen-yl)-4-oxo-4H-chromene-3-carboxamide, C16H10BrNO3, N-(4-iodo-phen-yl)-4-oxo-4H-chromene-3-carboxamide, C16H10INO3, have been structurally characterized. The mol-ecules are essentially planar and each exhibits an anti conformation with respect to the C-N rotamer of the amide and a cis geometry with respect to the relative positions of the Carom-Carom bond of the chromone ring and the carbonyl group of the amide. The structures each exhibit an intra-molecular hydrogen-bonding network comprising an N-H⋯O hydrogen bond between the amide N atom and the O atom of the carbonyl group of the pyrone ring, forming an S(6) ring, and a weak Carom-H⋯O inter-action with the O atom of the carbonyl group of the amide as acceptor, which forms another S(6) ring. All four compounds have the same supra-molecular structure, consisting of R 2 (2)(13) rings that are propagated along the a-axis direction by unit translation. There is π-π stacking involving inversion-related mol-ecules in each structure.

Entities:  

Keywords:  chromones; conformation; crystal structure; drug design; supra­molecular structure

Year:  2015        PMID: 25705460      PMCID: PMC4331845          DOI: 10.1107/S2056989014027054

Source DB:  PubMed          Journal:  Acta Crystallogr E Crystallogr Commun


Chemical context

Chromones are a group of natural and synthetic n class="Chemical">oxygen heterocyclic compounds having a high degree of chemical diversity that is frequently linked to a broad array of biological activities (Gaspar et al. 2014 ▸). Parkinson’s disease (PD) is a degenerative disorder of the central nervous system with an aetiology not yet completely clarified. There is no cure for PD, but medications, surgery and multidisciplinary management can provide relief from the symptoms. PD seems to be associated with a decrease in central levels of dopamine triggered by oxidative stress. These processes, among other factors, are mediated by the isoform B of the mono­amino oxidase (MAO-B). Hence, the search for novel agents that can selectively inhibit MAO-B is of paramount relevance. In this context, the decoration of chromone, a privileged structure for the discovery and development of new chemical entities (NCEs), have led to the preparation of chromone carboxamides and to promising outcomes since preliminary data indicate that chromone-3-carboxamides are selective MAO-B inhibitors (Gaspar, Reis et al., 2011 ▸; Gaspar, Silva et al., 2011 ▸). Previous results showed that the carbonyl group of the chromone moiety and the n class="Chemical">amide function play an important role in the establishment of hydrogen inter­actions with the MAO-B active pocket. In addition, the presence of a phenyl substituent attached to the amide seems to play a pivotal role in the potency conveyed by the ligand (Helguera et al., 2013 ▸). In this context, some N-(4-halophen­yl)-4-oxo-4H-chromene-3-carboxamides (1)–(4), shown in the scheme, have been synthesized and structurally characterized in order to rationalize the structural factors that may affect the selectivity and the potency of their inhibitory activities towards MAO-B. These structures are compared with N-(4-phen­yl)-4-oxo-4H-chromene-2-carboxamide and N-(4-bromo­phen­yl)-4-oxo-4H-chromene-2-carboxamide, compounds (5) and (6) (Reis et al., 2013 ▸; Gomes et al., 2013 ▸), which do not show inhibitory activities against human MAO-B.

Structural commentary

The structural analysis of (1)–(4) confirmed them to be N-(4-halophen­yl)-4-oxo-4H-n class="Chemical">chromene-3-carboxamides with halosubstituents F (Fig. 1 ▸), Cl (Fig. 2 ▸), Br (Fig. 3 ▸) and I (Fig. 4 ▸), respectively, as depicted in the scheme. Figs. 1 ▸–4 ▸ ▸ ▸ show the displacement ellipsoid diagrams with the adopted labelling schemes. All compounds crystallize in the space group P . Compounds (1) and (2) are isostructural, as are compounds (3) and (4). The cell lengths are very similar in each pair of compounds.
Figure 1

A view of the asymmetric unit of (1), showing the atom-numbering scheme. Displacement ellipsoids are drawn at the 80% probability level. Dashed lines indicate the intra­molecular contacts.

Figure 2

A view of the asymmetric unit of (2), showing the atom-numbering scheme. Displacement ellipsoids are drawn at the 80% probability level. Dashed lines indicate the intra­molecular contacts.

Figure 3

A view of the asymmetric unit of (3), showing the atom-numbering scheme. Displacement ellipsoids are drawn at the 80% probability level. Dashed lines indicate the intra­molecular contacts.

Figure 4

A view of the asymmetric unit of (4), showing the atom-numbering scheme. Displacement ellipsoids are drawn at the 80% probability level. Dashed lines indicate the intra­molecular contacts.

The title compounds display similar structures, which are reflected in the mol­ecular geometries and conformations; the values of the dihedral angles between the mean planes of the chromone ring and the exocyclic phenyl ring of the n class="Chemical">N-phenyl-4-oxo-4H-chromene-3-carboxamides are close to 2° in the case of the F, Cl pair [2.51 (3) and 1.95 (7)°, respectively,] and close to 5° for the Br, I pair [4.90 (10) and 5.37 (10)°, respectively]. In N-phenyl-4-oxo-4H-chromene-2-carboxamide (5) (Reis et al., 2013 ▸), the dihedral angle between the mean planes of the chromone ring and the phenyl ring is 6.57° and in N-(4-bromo­phen­yl)-4-oxo-4H-chromene-2-carboxamide (6), the structural isomer of (3) (Gomes et al., 2013 ▸), the dihedral angle between the mean planes of the chromone ring and the phenyl ring is 5.0 (2)°. Selected dihedral angles are given in Table 1 ▸.
Table 1

Selected dihedral angles ()

1 is the dihedral angle between the mean planes of the chromene and phenyl rings and the phenyl ring. 2 is the dihedral angle between the mean plane of the chromone ring and the plane defined by atoms O2, C31 and N3. 3 is the dihedral angle between the mean planes of the phenyl ring and the plane defined by atoms O3, C31 and N3.

Compound 1 2 3
(1)2.51(3)5.51(12)5.05(13)
(2)1.95(7)5.7(3)4.4(3)
(3)4.90(10)2.0(4)2.9(4)
(4)5.37(10)1.8(4)3.6(4)
In (1) and (2), the maximum deviations from the mean plane of the 10 atoms of the chromone ring plus the three n class="Chemical">carboxamide atoms O3, C31 and N3, are 0.1220 (8) and 0.1319 (17) Å, respectively, both for atom O3 (r.m.s. deviations of fitted atoms = 0.0519 and 0.0571 Å, respectively). In (3) and (4), the deviations of O3 from the mean plane defined above are 0.0384 (14) and 0.0342 (15) Å, respectively (r.m.s. deviations of fitted atoms = 0.0314 Å in both compounds). In the case of (3) and (4), atom C2 shows the greatest deviation from the mean plane having deviations of 0.0569 (18) and 0.0596 (18) Å, respectively. These values indicate that the carboxamide groups are practically planar with the chromone ring, particularly in the case of the Br and I chromone carboxamide derivatives. This planarity may be related to the inter­nal hydrogen-bond pattern in those mol­ecules, which thus defines the mol­ecular conformations. The conformational features herein established are probably most relevant for the extrapolation of the inhibitory MAO-B activities of n class="Chemical">chromone carboxamides as they are related to the inter­molecular forces responsible for enzyme–ligand binding affinity. The data can explain the MAO-B selectivity found for chromone-3-carboxamides (1)–(4), as opposed to the lack of activity presented by chromone-2-carboxamides (5) and (6). As seen in the scheme, (1)–(4) are N-(phen­yl)-4-oxo-4H-chromene-3-carboxamides while (5) and (6) are N-(phen­yl)-4-oxo-4H-chromene-2-carboxamides. As can be seen in Fig. 5 ▸, an anti conformation is adopted with respect to the C—N rotamer of the amide in all of the compounds. Nevertheless, due to the asymmetry of the chromone residue, the anti conformation can assume a cis (a) or trans (b) geometry with respect to the relative position of the carbonyl O atom of the carboxamide and the C2arom—C3arom bond of the chromone. Compounds (1)–(4) exhibit a cis relation between these bonds, as can be seen in the ellipsoid diagrams, Figs. 1 ▸–4 ▸ ▸ ▸. This mol­ecular conformation permits the formation of two intra­molecular hydrogen bonds, which generate a network that probably enhances their planarity. Details of the intra­molecular hydrogen-bonding inter­actions are given in Tables 2 ▸ ▸ ▸ to 5 ▸. Specifically for each mol­ecule, there is an intra­molecular N—H⋯O hydrogen bond between the amide nitro­gen and the oxygen atom of the carbonyl group, O4, of the chromone ring, forming an S(6) ring identified as ring C. In addition, the carbonyl oxygen of the amide, O3, acts as the acceptor for a weak inter­action with an ortho hydrogen of the exocyclic phenyl ring, forming another S(6) ring, B. The corresponding trans structures (top right in Fig. 5 ▸) would probably only allow the formation of a weak hydrogen-bonding inter­action with an ortho hydrogen atom of the exocyclic phenyl ring. It is inter­esting to compare the inter­nal hydrogen-bonding network presented by the title compounds with those of the analogous 4-oxo-N-(substituted phen­yl)-4H-chromene-2-carboxamides (Reis et al., 2013 ▸) and (Gomes et al., 2013 ▸), compounds (5) and (6). Previous studies concerning the structures of the chromone-2-carboxamides show that the majority have geometries similar to compound (5), e.g. as in (1)–(4), they assume a cis conformation, but this is not the case for (6), the bromo isomer of (3), as shown in Fig. 5 ▸ (bottom right). In spite of this, none of this type of derivative displays inhibitory activity towards the MAO-B isoenzyme. When the geometries of the relative positions of rings D and E of the chromone residue with respect to rings A and B are compared, it can be seen that the effect of the 2/3 positional isomerism is to ‘reflect’ their relative positions while the effect of the cis/trans conformations is a ‘twofold rotation’ of the rings around the CamideCchromone bond. Those particular differences in conformation may condition the ability for docking when pharmacological activities are considered.
Figure 5

Anti-rotamer conformations around the C—N rotamer for the 3-carboxamides (top) and for the 2-carboxamide isomers (bottom), showing the relative positions of the C3arom—C2arom bond of the chromone ring with respect to the carb­oxy­lic group of the amide: cis (right) or trans (left) geometries.

Table 2

Hydrogen-bond geometry (, ) for (1)

DHA DHHA D A DHA
N3H3O40.896(17)1.901(17)2.7024(13)147.9(15)
C312H312O30.952.262.8714(15)122
C2H2O4i 0.952.453.1645(14)132
C316H316O3ii 0.952.463.3160(14)149

Symmetry codes: (i) ; (ii) .

Table 3

Hydrogen-bond geometry (, ) for (2)

DHA DHHA D A DHA
N3H3O40.85(3)1.92(3)2.680(3)148(3)
C312H312O30.952.292.892(3)121
C2H2O4i 0.952.473.194(3)133
C316H316O3ii 0.952.453.286(3)146

Symmetry codes: (i) ; (ii) .

Table 4

Hydrogen-bond geometry (, ) for (3)

DHA DHHA D A DHA
N3H3O40.86(2)1.95(2)2.695(2)145(2)
C312H312O30.952.262.877(2)129
C2H2O4i 0.952.413.167(2)137
C316H316O3ii 0.952.473.314(2)148

Symmetry codes: (i) ; (ii) .

Table 5

Hydrogen-bond geometry (, ) for (4)

DHA DHHA D A DHA
N3H3O40.92(2)1.89(2)2.6977(19)145(2)
C2H2O30.952.332.718(2)104
C312H312O30.952.272.881(2)122
C2H2O4i 0.952.443.185(2)136
C316H316O3ii 0.952.493.312(2)145

Symmetry codes: (i) ; (ii) .

Supra­molecular features

Inter­molecular hydrogen-bonding information is given in Table 2 ▸ to 5. All compounds have the same supra­molecular structure in which the C2—n class="Chemical">H2⋯O4(x + 1, y, z) and C316H316⋯O3(x − 1, y, z) form (13) ring structures, which are propagated along the a-axis direction by unit translation. Fig. 6 ▸ shows the Cl compound, (3), as an example.
Figure 6

The distorted ladder formed by linked (13) rings in compound (3). The chain runs parallel to the a axis. Hydrogen bonds are indicated by blue dashed lines. Hydrogen atoms not involved in the hydrogen bonding have been omitted for clarity. A similar structure is found for compound (1) and all the halo-substituted compounds. [Symmetry codes: (i) x + 1, y, z; (ii) x − 1, y, x.]

There is π–π stacking in each compound, involving inversion-related mol­ecules in all compounds, Table 6 ▸.
Table 6

stacking (, )

Cg1, Cg2, Cg3 and Cg7 [compound (6)] are the centroids of the rings containing atoms O1, C5, C311 and C211 [compound (6)], respectively. In contacts indicated *, the planes involved are inclined to each other, the perpendicular distance between the planes is an average value and the angle between the planes is given in place of a slippage. Only interplanar interactions with Cg Cg distances 4.0 and with angles between the planes of 10 are included.

Compoundcontactdistanceperp. dist.angle between planes
(1) Cg1Cg3iii 3.5187(8)3.3226*1.77(6)*
  Cg1Cg3iv 3.543(8)3.3719*1.77(6)*
(2) Cg1Cg3v 3.5341(17)3.3573*0.77(13)*
  Cg2Cg3vi 3.6691(17)3.3985*3.14(13)*
(3) Cg1Cg3v 3.5464(11)3.3342*4.66(9)*
(4) Cg1Cg3iii 3.5721(11)3.3518*5.37(9)

Symmetry codes: (iii) x+1, y+1, z+1; (iv) x, y+2, z; (v) x+1, y, z+1; (vi) x, y, z.

Synthesis and crystallization

The title compounds were obtained by synthetic strategies described elsewhere (Cagide et al., 2011 ▸). Chromone-3-carboxamides were synthesized using n class="Chemical">chromone-3-carb­oxy­lic acid as starting material which, after in situ activation with phospho­rus(V) oxychloride (POCl3) in di­methyl­formamide, react with the different haloanilines. Recrystallization from di­chloro­methane afforded colourless plates whose dimensions are given in Table 7 ▸.
Table 7

Experimental details

 (1)(2)(3)(4)
Crystal data
Chemical formulaC16H10FNO3 C16H10ClNO3 C16H10BrNO3 C16H10INO3
M r 283.25299.70344.16391.15
Crystal system, space groupTriclinic, P Triclinic, P Triclinic, P Triclinic, P
Temperature (K)100100120120
a, b, c ()6.6213(5), 7.0517(5), 14.0864(10)6.6325(12), 7.0577(12), 14.671(3)6.6505(5), 9.3580(7), 11.0060(8)6.6750(5), 9.4166(7), 11.2673(8)
, , ()101.957(7), 90.047(6), 106.657(7)103.536(7), 89.714(6), 105.589(7)100.280(6), 90.461(6), 100.884(6)100.974(6), 90.769(6), 100.062(6)
V (3)615.17(8)641.9(2)661.24(9)683.77(9)
Z 2222
Radiation typeMo K Mo K Mo K Mo K
(mm1)0.120.313.122.35
Crystal size (mm)0.46 0.32 0.020.17 0.17 0.040.58 0.18 0.060.46 0.22 0.05
 
Data collection
DiffractometerRigaku Saturn724+Rigaku AFC12Rigaku R-AXIS conversionRigaku R-AXIS conversion
Absorption correctionMulti-scan (CrystalClear-SM Expert; Rigaku, 2012)Multi-scan (CrystalClear-SM Expert; Rigaku, 2012)Multi-scan (CrystalClear-SM Expert; Rigaku, 2012)Multi-scan (CrystalClear-SM Expert; Rigaku, 2012)
T min, T max 0.949, 0.9980.950, 0.9880.265, 0.8350.411, 0.892
No. of measured, independent and observed [I > 2(I)] reflections8176, 2789, 23937435, 2265, 16689930, 3017, 252510032, 3095, 2819
R int 0.0560.0780.0450.026
(sin /)max (1)0.6490.5980.6490.649
 
Refinement
R[F 2 > 2(F 2)], wR(F 2), S 0.044, 0.135, 1.060.056, 0.145, 0.990.027, 0.058, 0.940.018, 0.044, 1.03
No. of reflections2789226530173095
No. of parameters194194194194
H-atom treatmentH atoms treated by a mixture of independent and constrained refinementH atoms treated by a mixture of independent and constrained refinementH atoms treated by a mixture of independent and constrained refinementH atoms treated by a mixture of independent and constrained refinement
max, min (e 3)0.41, 0.270.30, 0.650.53, 0.690.67, 0.32

Computer programs: CrystalClear-SM Expert (Rigaku, 2012 ▸), SHELXS97 and SHELXL2014 (Sheldrick, 2008 ▸), PLATON (Spek, 2009 ▸) Flipper 25 (Oszlnyi St, 2004 ▸), OSCAIL (McArdle et al., 2004 ▸), ShelXle (Hbschle et al., 2011 ▸), Mercury (Macrae et al., 2006 ▸) and OSCAIL (McArdle et al., 2004 ▸).

Refinement

Crystal data, data collection and structure refinement details are summarized in Table 7 ▸. Amino H atoms were located in difference Fourier maps and were refined isotropically. All other n class="Disease">H atoms were treated as riding atoms with C—H(aromatic) = 0.95 Å, U iso= 1.2Ueq(C). Compounds (1) and (2), reduced cell: [a = 6.6325 (12), b = 0.0577 (12), c = 14.671 (3) Å, α = 76.464 (7), β = 89.714 (6), γ = 74.411 (7)°, V = 641.9 (2) Å3], have different reduced cells in which the x and z coordinates are comparable and the y coordinate of (2) is close to 1 − y of (1). For ease of comparison of the structures of (1) and (2), the refinement reported here was carried out for the non-reduced cell of (2) in which the α and γ angles were given the supplementary values of those of the reduced unit cell. The coordinates of (1) were used as starting values and the transformation matrix for the reduced to non-reduced cell was 0 0 0 1 0 0 0 . This gave the same final refinement values as those for the refinement with the reduced cell. Compounds (1) and (2) are therefore isostructural. Crystal structure: contains datablock(s) 1, 2, 3, 4, global. DOI: 10.1107/S2056989014027054/lh5743sup1.cif Structure factors: contains datablock(s) 1. DOI: 10.1107/S2056989014027054/lh57431sup2.hkl Structure factors: contains datablock(s) 2. DOI: 10.1107/S2056989014027054/lh57432sup3.hkl Structure factors: contains datablock(s) 3. DOI: 10.1107/S2056989014027054/lh57433sup4.hkl Structure factors: contains datablock(s) 4. DOI: 10.1107/S2056989014027054/lh57434sup5.hkl Click here for additional data file. Supporting information file. DOI: 10.1107/S2056989014027054/lh57431sup6.cml Click here for additional data file. Supporting information file. DOI: 10.1107/S2056989014027054/lh57432sup7.cml Click here for additional data file. Supporting information file. DOI: 10.1107/S2056989014027054/lh57433sup8.cml Click here for additional data file. Supporting information file. DOI: 10.1107/S2056989014027054/lh57434sup9.cml CCDC references: 1038511, 1038510, 1038509, 1038508 Additional supporting information: crystallographic information; 3D view; checkCIF report
C16H10INO3Z = 2
Mr = 391.15F(000) = 380
Triclinic, P1Dx = 1.900 Mg m3
a = 6.6750 (5) ÅMo Kα radiation, λ = 0.71075 Å
b = 9.4166 (7) ÅCell parameters from 9236 reflections
c = 11.2673 (8) Åθ = 1.8–27.5°
α = 100.974 (6)°µ = 2.35 mm1
β = 90.769 (6)°T = 120 K
γ = 100.062 (6)°Plate, colourless
V = 683.77 (9) Å30.46 × 0.22 × 0.05 mm
Rigaku RAXIS conversion diffractometer3095 independent reflections
Radiation source: Sealed Tube2819 reflections with I > 2σ(I)
Graphite Monochromator monochromatorRint = 0.026
Detector resolution: 10.0000 pixels mm-1θmax = 27.5°, θmin = 2.2°
profile data from ω–scansh = −7→8
Absorption correction: multi-scan (CrystalClear-SM Expert; Rigaku, 20112)k = −12→11
Tmin = 0.411, Tmax = 0.892l = −14→14
10032 measured reflections
Refinement on F20 restraints
Least-squares matrix: fullHydrogen site location: mixed
R[F2 > 2σ(F2)] = 0.018H atoms treated by a mixture of independent and constrained refinement
wR(F2) = 0.044w = 1/[σ2(Fo2) + (0.026P)2] where P = (Fo2 + 2Fc2)/3
S = 1.03(Δ/σ)max = 0.002
3095 reflectionsΔρmax = 0.67 e Å3
194 parametersΔρmin = −0.32 e Å3
Geometry. All e.s.d.'s (except the e.s.d. in the dihedral angle between two l.s. planes) are estimated using the full covariance matrix. The cell e.s.d.'s are taken into account individually in the estimation of e.s.d.'s in distances, angles and torsion angles; correlations between e.s.d.'s in cell parameters are only used when they are defined by crystal symmetry. An approximate (isotropic) treatment of cell e.s.d.'s is used for estimating e.s.d.'s involving l.s. planes.
xyzUiso*/Ueq
I3140.09431 (2)0.28556 (2)0.97093 (2)0.02278 (5)
O10.88205 (19)0.94124 (14)0.35573 (11)0.0188 (3)
O30.7838 (2)0.68549 (15)0.60794 (12)0.0219 (3)
O40.28854 (19)0.79085 (14)0.42255 (11)0.0199 (3)
N30.4362 (2)0.65097 (16)0.58280 (13)0.0152 (3)
H30.337 (3)0.678 (2)0.5384 (19)0.017 (5)*
C20.8340 (3)0.85191 (19)0.43445 (15)0.0166 (3)
H20.94340.82300.47310.020*
C30.6432 (3)0.79929 (17)0.46363 (14)0.0144 (3)
C40.4692 (3)0.83443 (18)0.40253 (14)0.0144 (3)
C4A0.5235 (3)0.92875 (18)0.31366 (14)0.0149 (3)
C50.3733 (3)0.9701 (2)0.24576 (16)0.0193 (4)
H50.23340.93520.25570.023*
C60.4280 (3)1.0611 (2)0.16480 (16)0.0221 (4)
H60.32571.08650.11760.026*
C70.6338 (3)1.1164 (2)0.15168 (16)0.0217 (4)
H70.66961.18110.09710.026*
C80.7853 (3)1.0777 (2)0.21751 (16)0.0211 (4)
H80.92491.11540.20940.025*
C8A0.7265 (3)0.98182 (19)0.29605 (15)0.0167 (3)
C3110.3707 (3)0.56515 (18)0.66915 (14)0.0147 (3)
C3120.5034 (3)0.52301 (19)0.74728 (15)0.0170 (3)
H3120.64660.55010.74260.020*
C3130.4242 (3)0.4409 (2)0.83219 (15)0.0183 (3)
H3130.51340.41190.88570.022*
C3140.2148 (3)0.40150 (18)0.83828 (15)0.0167 (3)
C3150.0823 (3)0.44141 (19)0.75977 (15)0.0178 (3)
H315−0.06080.41270.76370.021*
C3160.1603 (3)0.52325 (19)0.67578 (15)0.0171 (3)
H3160.07020.55120.62210.020*
C310.6294 (3)0.70661 (18)0.55846 (15)0.0154 (3)
U11U22U33U12U13U23
I3140.02679 (8)0.02415 (7)0.01880 (6)0.00303 (5)0.00371 (4)0.00890 (4)
O10.0120 (6)0.0209 (6)0.0242 (6)0.0014 (5)0.0022 (5)0.0074 (5)
O30.0143 (6)0.0284 (7)0.0258 (7)0.0053 (5)−0.0013 (5)0.0108 (5)
O40.0116 (6)0.0256 (7)0.0248 (6)0.0024 (5)0.0016 (5)0.0116 (5)
N30.0136 (7)0.0169 (7)0.0164 (7)0.0040 (6)−0.0002 (5)0.0057 (5)
C20.0139 (8)0.0165 (8)0.0192 (8)0.0035 (6)−0.0004 (6)0.0027 (6)
C30.0138 (8)0.0129 (8)0.0158 (7)0.0027 (6)0.0005 (6)0.0005 (6)
C40.0132 (8)0.0146 (8)0.0151 (7)0.0027 (6)0.0006 (6)0.0018 (6)
C4A0.0157 (9)0.0141 (8)0.0146 (7)0.0031 (6)0.0021 (6)0.0017 (6)
C50.0169 (9)0.0217 (9)0.0195 (8)0.0036 (7)0.0019 (6)0.0045 (6)
C60.0260 (10)0.0246 (9)0.0186 (8)0.0088 (8)0.0007 (7)0.0078 (7)
C70.0283 (10)0.0197 (9)0.0198 (8)0.0066 (7)0.0080 (7)0.0078 (6)
C80.0202 (10)0.0193 (9)0.0236 (9)0.0024 (7)0.0066 (7)0.0047 (7)
C8A0.0161 (9)0.0155 (8)0.0181 (8)0.0035 (6)0.0026 (6)0.0016 (6)
C3110.0166 (9)0.0127 (8)0.0145 (7)0.0034 (6)0.0011 (6)0.0014 (6)
C3120.0147 (9)0.0183 (8)0.0186 (8)0.0041 (7)−0.0002 (6)0.0038 (6)
C3130.0199 (9)0.0198 (8)0.0164 (8)0.0065 (7)−0.0023 (6)0.0038 (6)
C3140.0203 (9)0.0148 (8)0.0149 (7)0.0018 (7)0.0026 (6)0.0039 (6)
C3150.0148 (9)0.0199 (9)0.0183 (8)0.0030 (7)0.0018 (6)0.0029 (6)
C3160.0164 (9)0.0171 (8)0.0184 (8)0.0055 (7)−0.0014 (6)0.0027 (6)
C310.0161 (9)0.0140 (8)0.0157 (7)0.0036 (6)0.0007 (6)0.0010 (6)
I314—C3142.1023 (17)C6—C71.401 (3)
O1—C21.340 (2)C6—H60.9500
O1—C8A1.376 (2)C7—C81.385 (3)
O3—C311.229 (2)C7—H70.9500
O4—C41.243 (2)C8—C8A1.394 (2)
N3—C311.357 (2)C8—H80.9500
N3—C3111.406 (2)C311—C3121.397 (2)
N3—H30.92 (2)C311—C3161.398 (3)
C2—C31.352 (2)C312—C3131.395 (3)
C2—H20.9500C312—H3120.9500
C3—C41.460 (2)C313—C3141.388 (3)
C3—C311.497 (2)C313—H3130.9500
C4—C4A1.469 (2)C314—C3151.389 (2)
C4A—C8A1.390 (2)C315—C3161.383 (2)
C4A—C51.404 (2)C315—H3150.9500
C5—C61.377 (3)C316—H3160.9500
C5—H50.9500
C2—O1—C8A118.48 (14)C7—C8—H8121.0
C31—N3—C311128.55 (15)C8A—C8—H8121.0
C31—N3—H3114.0 (15)O1—C8A—C4A121.30 (15)
C311—N3—H3117.4 (15)O1—C8A—C8116.04 (16)
O1—C2—C3125.61 (16)C4A—C8A—C8122.66 (17)
O1—C2—H2117.2C312—C311—C316119.80 (16)
C3—C2—H2117.2C312—C311—N3123.60 (16)
C2—C3—C4119.41 (15)C316—C311—N3116.59 (15)
C2—C3—C31115.53 (15)C313—C312—C311119.53 (17)
C4—C3—C31125.07 (15)C313—C312—H312120.2
O4—C4—C3124.22 (16)C311—C312—H312120.2
O4—C4—C4A121.28 (16)C314—C313—C312119.87 (16)
C3—C4—C4A114.49 (15)C314—C313—H313120.1
C8A—C4A—C5118.05 (16)C312—C313—H313120.1
C8A—C4A—C4120.59 (16)C313—C314—C315120.84 (16)
C5—C4A—C4121.35 (16)C313—C314—I314120.05 (13)
C6—C5—C4A120.26 (18)C315—C314—I314119.08 (13)
C6—C5—H5119.9C316—C315—C314119.42 (17)
C4A—C5—H5119.9C316—C315—H315120.3
C5—C6—C7120.37 (18)C314—C315—H315120.3
C5—C6—H6119.8C315—C316—C311120.53 (16)
C7—C6—H6119.8C315—C316—H316119.7
C8—C7—C6120.65 (17)C311—C316—H316119.7
C8—C7—H7119.7O3—C31—N3124.75 (16)
C6—C7—H7119.7O3—C31—C3121.00 (16)
C7—C8—C8A117.95 (17)N3—C31—C3114.25 (15)
C8A—O1—C2—C3−1.7 (2)C4—C4A—C8A—C8−176.55 (16)
O1—C2—C3—C43.0 (3)C7—C8—C8A—O1177.28 (15)
O1—C2—C3—C31−177.33 (15)C7—C8—C8A—C4A−2.4 (3)
C2—C3—C4—O4179.64 (16)C31—N3—C311—C3120.3 (3)
C31—C3—C4—O40.0 (3)C31—N3—C311—C316179.48 (16)
C2—C3—C4—C4A−0.9 (2)C316—C311—C312—C313−0.7 (2)
C31—C3—C4—C4A179.46 (15)N3—C311—C312—C313178.37 (16)
O4—C4—C4A—C8A177.21 (15)C311—C312—C313—C3140.1 (3)
C3—C4—C4A—C8A−2.3 (2)C312—C313—C314—C3150.8 (3)
O4—C4—C4A—C5−1.7 (3)C312—C313—C314—I314−177.36 (13)
C3—C4—C4A—C5178.81 (15)C313—C314—C315—C316−1.0 (3)
C8A—C4A—C5—C6−0.2 (3)I314—C314—C315—C316177.17 (12)
C4—C4A—C5—C6178.65 (16)C314—C315—C316—C3110.3 (3)
C4A—C5—C6—C7−1.7 (3)C312—C311—C316—C3150.5 (3)
C5—C6—C7—C81.6 (3)N3—C311—C316—C315−178.64 (15)
C6—C7—C8—C8A0.4 (3)C311—N3—C31—O32.5 (3)
C2—O1—C8A—C4A−1.8 (2)C311—N3—C31—C3−177.41 (15)
C2—O1—C8A—C8178.47 (15)C2—C3—C31—O32.3 (2)
C5—C4A—C8A—O1−177.34 (15)C4—C3—C31—O3−178.01 (15)
C4—C4A—C8A—O13.7 (2)C2—C3—C31—N3−177.74 (14)
C5—C4A—C8A—C82.4 (3)C4—C3—C31—N31.9 (2)
D—H···AD—HH···AD···AD—H···A
N3—H3···O40.92 (2)1.89 (2)2.6977 (19)145 (2)
C2—H2···O30.952.332.718 (2)104
C312—H312···O30.952.272.881 (2)122
C2—H2···O4i0.952.443.185 (2)136
C316—H316···O3ii0.952.493.312 (2)145
  10 in total

1.  Ab initio structure solution by charge flipping.

Authors:  Gábor Oszlányi; András Süto
Journal:  Acta Crystallogr A       Date:  2004-02-17       Impact factor: 2.290

2.  A short history of SHELX.

Authors:  George M Sheldrick
Journal:  Acta Crystallogr A       Date:  2007-12-21       Impact factor: 2.290

Review 3.  Chromone: a valid scaffold in medicinal chemistry.

Authors:  Alexandra Gaspar; Maria João Matos; Jorge Garrido; Eugenio Uriarte; Fernanda Borges
Journal:  Chem Rev       Date:  2014-02-21       Impact factor: 60.622

4.  Chromone 3-phenylcarboxamides as potent and selective MAO-B inhibitors.

Authors:  Alexandra Gaspar; Joana Reis; André Fonseca; Nuno Milhazes; Dolores Viña; Eugenio Uriarte; Fernanda Borges
Journal:  Bioorg Med Chem Lett       Date:  2010-12-05       Impact factor: 2.823

5.  4-Oxo-N-phenyl-4H-chromene-2-carboxamide and of a new polymorph of 7-methoxy-4-oxo-N-p-tolyl-4H-chromene-2-carboxamide and its hemihydrate.

Authors:  Joana Reis; Alexandra Gaspar; Fernanda Borges; Ligia R Gomes; John Nicolson Low
Journal:  Acta Crystallogr C       Date:  2013-11-13       Impact factor: 1.172

6.  Chromone, a privileged scaffold for the development of monoamine oxidase inhibitors.

Authors:  Alexandra Gaspar; Tiago Silva; Matilde Yáñez; Dolores Vina; Franscisco Orallo; Francesco Ortuso; Eugenio Uriarte; Stefano Alcaro; Fernanda Borges
Journal:  J Med Chem       Date:  2011-07-01       Impact factor: 7.446

7.  Structural characterization of some N-phenyl-4-oxo-4H-2-chromone carboxamides.

Authors:  Ligia Rebelo Gomes; John Nicolson Low; Fernando Cagide; Alexandra Gaspar; Joana Reis; Fernanda Borges
Journal:  Acta Crystallogr B Struct Sci Cryst Eng Mater       Date:  2013-05-08

8.  Combining QSAR classification models for predictive modeling of human monoamine oxidase inhibitors.

Authors:  Aliuska Morales Helguera; Alfonso Pérez-Garrido; Alexandra Gaspar; Joana Reis; Fernando Cagide; Dolores Vina; M Natália D S Cordeiro; Fernanda Borges
Journal:  Eur J Med Chem       Date:  2012-11-01       Impact factor: 6.514

9.  ShelXle: a Qt graphical user interface for SHELXL.

Authors:  Christian B Hübschle; George M Sheldrick; Birger Dittrich
Journal:  J Appl Crystallogr       Date:  2011-11-12       Impact factor: 3.304

10.  Structure validation in chemical crystallography.

Authors:  Anthony L Spek
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2009-01-20
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.